Global Intravenous System Access Devices Market Size By Type (Catheters, Needles), By Application (Hospitals and clinics, Ambulatory surgery centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Intravenous (IV) System Access Devices Market was valued at USD 8.1 billion in 2023 and is projected to reach USD 13.9 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. IV access devices are essential in clinical practice for administering fluids, medications, and nutrition, especially in emergency and chronic care settings. The market is experiencing significant growth due to rising hospitalization rates, the growing prevalence of chronic diseases, technological innovations in catheter materials and safety features, and the increasing number of surgical procedures worldwide.

Drivers:

1. Rising Chronic Disease Burden:

The growing global prevalence of conditions like cancer, diabetes, and cardiovascular diseases is increasing the need for continuous intravenous therapy, fueling demand for access devices.

2. Increased Hospitalization and Surgical Procedures:

As healthcare systems experience higher patient admissions, the use of IV access devices in procedures, diagnostics, and therapy continues to expand rapidly.

3. Technological Advancements in Device Safety and Design:

Innovations such as needleless connectors, antimicrobial-coated catheters, and improved biocompatibility are enhancing patient safety and reducing infection risks, making these devices more desirable.

Restraints:

1. Risk of Catheter-Associated Infections:

Despite advancements, catheter-associated bloodstream infections (CLABSIs) remain a major concern, which can impact adoption in sensitive populations.

2. Regulatory Hurdles and Product Recalls:

Strict regulatory environments and the possibility of product recalls due to safety concerns can hinder market growth and disrupt supply chains.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Countries in Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, presenting untapped opportunities for IV system access device manufacturers.

2. Integration with Digital Health Platforms:

Smart IV systems that monitor flow rates and complications in real-time are gaining traction, representing a major growth area for innovation-focused companies.

Market by System Type Insights:

The Peripheral Intravenous Catheter (PIVC) segment led the market in 2023 due to its widespread application in general hospital and outpatient settings. However, the Central Venous Catheter (CVC) and Implantable Ports segments are projected to grow at a faster pace owing to their importance in long-term therapies such as chemotherapy and parenteral nutrition.

Market by End-use Insights:

Hospitals dominated the global IV system access devices market in 2023, accounting for over 50% of revenue. The high frequency of surgical and emergency care cases drives this segment. Home healthcare is expected to exhibit the fastest growth due to the shift toward outpatient care and aging populations requiring long-term intravenous therapy at home.

Market by Regional Insights:

North America held the largest market share in 2023, driven by a well-established healthcare infrastructure and a high prevalence of chronic diseases. Asia-Pacific is forecast to witness the highest growth during the forecast period due to increasing healthcare expenditure, growing awareness, and expanding access to advanced medical technologies in countries like China and India.

Competitive Scenario:

Major players operating in the global IV system access devices market include:

Becton, Dickinson and Company (BD)

B. Braun Melsungen AG

Teleflex Incorporated

ICU Medical, Inc.

Smiths Medical

Terumo Corporation

AngioDynamics, Inc.

Nipro Corporation

Vygon Group

Poly Medicure Ltd.

These companies are focusing on product innovation, strategic acquisitions, and geographical expansion to strengthen their positions in the market.

Scope of Work – Global Intravenous System Access Devices Market

Report Metric Details

Market Size (2023) USD 8.1 billion

Projected Market Size (2031) USD 13.9 billion

CAGR (2023–2031) 7.0%

Market Segments By System Type (PIVC, CVC, Implantable Ports, Others), By End-use (Hospitals, Ambulatory Surgical Centers, Home Healthcare)

Growth Drivers Rising chronic disease prevalence, growth in surgical procedures, advancements in IV access technology

Opportunities Emerging markets expansion, digital health integration

Key Market Developments:

In 2023, BD launched its next-generation safety IV catheter designed to reduce needlestick injuri